Apr 15 Practical recommendations for the perioperative management of patients with suspected or severe SARS-CoV-2 coronavirus infection
A. Montero Feijoo, E. Maseda, R. Adalia Bartolomé, G. Aguilar, R. González de Castro, JI Gómez-Herreras, C. García Palenciano, J. Pereira, F. Ramasco Rueda, E. Samso, A. Suárez de la Rica, G. Tamayo Medel and M. Varela Durán, on behalf of the Perioperative Infection Working Group of the Spanish Society of Anesthesiology and Resuscitation (GTIPO-SEDAR)
ABSTRACT
In December 2019, the Wuhan Municipal Health and Sanitation Commission (Hubei Province, China) reported a series of cases of pneumonia of unknown etiology. On January 7, 2020, the Chinese authorities identified a new type of virus from the Coronaviridae family, called SARS-CoV-2, as the causative agent of the outbreak. Since then, thousands of cases with a global spread have been reported. Infections in humans cause a wide clinical spectrum ranging from mild upper respiratory tract infection to severe acute respiratory distress syndrome and sepsis. There is no specific treatment for SARS-CoV-2, which is why the fundamental aspects are to establish adequate prevention measures and support treatment and management of complications.